NYSE •
Healthcare •
Diagnostics & Research •
Quote as of 05/13/2026 16:00
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeNYSE
Market Capitalization6,808.71 mln
Float205 mln
Earnings Date08/11/2026
EPS
1.96
Moderate
P / E
16.68
Moderately valued
Piotroski F-Score
8
/ 9
Very strong
Beneish M-Score
-2.58
Likely reliable
1-Year Forecast
46.32
Exceptional upside
Relative Strength
19
/ 100
Significantly lagging
Business Description
Founded in 1984 and based in Venlo, the Netherlands, Qiagen N.V. is a global company that helps researchers and medical professionals extract meaningful information from biological samples. It supplies a broad range of tools and kits for processing and analyzing genetic material, along with instruments that support testing in areas such as cancer, infectious disease, prenatal health, and forensics. The company also provides software and data analysis services to help customers interpret complex genetic information.
